A Study in Subjects With Late Prodromal & Early Manifest HD to Assess the Safety, Tolerability, pk, and Efficacy of Pepi

Clinical trial NCT02481674 · COMPLETED

Trial details

NCT number: NCT02481674
Sponsor: Vaccinex Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Huntington's Disease

Start date: 2015-07-01
Primary completion: 2020-08-01
Enrollment: 301

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.